 | • レポートコード：MRC2-11QY07605 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメニエール病治療薬のグローバル市場について調査・分析したレポートです。種類別（前庭阻害剤、抗コリン作用薬、血管拡張薬、利尿薬脱水薬、糖質コルチコイド、その他）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メニエール病治療薬の競争状況、市場シェア ・世界のメニエール病治療薬市場：種類別市場規模 2015年-2020年（前庭阻害剤、抗コリン作用薬、血管拡張薬、利尿薬脱水薬、糖質コルチコイド、その他） ・世界のメニエール病治療薬市場：種類別市場規模予測 2021年-2026年（前庭阻害剤、抗コリン作用薬、血管拡張薬、利尿薬脱水薬、糖質コルチコイド、その他） ・世界のメニエール病治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅ケア） ・世界のメニエール病治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅ケア） ・北米のメニエール病治療薬市場分析：米国、カナダ ・ヨーロッパのメニエール病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメニエール病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメニエール病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメニエール病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Orbis Biosciences Inc、Otonomy Inc、Quark Pharmaceuticals Inc、Sound Pharmaceuticals Inc、Synphora AB ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Meniere Disease Drugs Market
The global Meniere Disease Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Meniere Disease Drugs Scope and Market Size
Meniere Disease Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meniere Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Meniere Disease Drugs market is segmented into
Vestibular Inhibitors
Anticholinergics
Vasodilator
Diuretic Dehydration Medicine
Glucocorticoids
Others
Segment by Application, the Meniere Disease Drugs market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Meniere Disease Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Meniere Disease Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meniere Disease Drugs Market Share Analysis
Meniere Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meniere Disease Drugs business, the date to enter into the Meniere Disease Drugs market, Meniere Disease Drugs product introduction, recent developments, etc.
The major vendors covered:
Orbis Biosciences Inc
Otonomy Inc
Quark Pharmaceuticals Inc
Sound Pharmaceuticals Inc
Synphora AB
…
1 Study Coverage
1.1 Meniere Disease Drugs Product Introduction
1.2 Market Segments
1.3 Key Meniere Disease Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meniere Disease Drugs Market Size Growth Rate by Type
1.4.2 Vestibular Inhibitors
1.4.3 Anticholinergics
1.4.4 Vasodilator
1.4.5 Diuretic Dehydration Medicine
1.4.6 Glucocorticoids
1.4.7 Others
1.5 Market by Application
1.5.1 Global Meniere Disease Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meniere Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Meniere Disease Drugs Revenue 2015-2026
2.1.2 Global Meniere Disease Drugs Sales 2015-2026
2.2 Global Meniere Disease Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Meniere Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meniere Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Meniere Disease Drugs Competitor Landscape by Players
3.1 Meniere Disease Drugs Sales by Manufacturers
3.1.1 Meniere Disease Drugs Sales by Manufacturers (2015-2020)
3.1.2 Meniere Disease Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Meniere Disease Drugs Revenue by Manufacturers
3.2.1 Meniere Disease Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Meniere Disease Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meniere Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meniere Disease Drugs Revenue in 2019
3.2.5 Global Meniere Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meniere Disease Drugs Price by Manufacturers
3.4 Meniere Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Meniere Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meniere Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Meniere Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meniere Disease Drugs Market Size by Type (2015-2020)
4.1.1 Global Meniere Disease Drugs Sales by Type (2015-2020)
4.1.2 Global Meniere Disease Drugs Revenue by Type (2015-2020)
4.1.3 Meniere Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meniere Disease Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Meniere Disease Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Meniere Disease Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Meniere Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meniere Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Meniere Disease Drugs Market Size by Application (2015-2020)
5.1.1 Global Meniere Disease Drugs Sales by Application (2015-2020)
5.1.2 Global Meniere Disease Drugs Revenue by Application (2015-2020)
5.1.3 Meniere Disease Drugs Price by Application (2015-2020)
5.2 Meniere Disease Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Meniere Disease Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Meniere Disease Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Meniere Disease Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Meniere Disease Drugs by Country
6.1.1 North America Meniere Disease Drugs Sales by Country
6.1.2 North America Meniere Disease Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meniere Disease Drugs Market Facts & Figures by Type
6.3 North America Meniere Disease Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Meniere Disease Drugs by Country
7.1.1 Europe Meniere Disease Drugs Sales by Country
7.1.2 Europe Meniere Disease Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meniere Disease Drugs Market Facts & Figures by Type
7.3 Europe Meniere Disease Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Meniere Disease Drugs by Region
8.1.1 Asia Pacific Meniere Disease Drugs Sales by Region
8.1.2 Asia Pacific Meniere Disease Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meniere Disease Drugs Market Facts & Figures by Type
8.3 Asia Pacific Meniere Disease Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Meniere Disease Drugs by Country
9.1.1 Latin America Meniere Disease Drugs Sales by Country
9.1.2 Latin America Meniere Disease Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meniere Disease Drugs Market Facts & Figures by Type
9.3 Central & South America Meniere Disease Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Meniere Disease Drugs by Country
10.1.1 Middle East and Africa Meniere Disease Drugs Sales by Country
10.1.2 Middle East and Africa Meniere Disease Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Meniere Disease Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Meniere Disease Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Orbis Biosciences Inc
11.1.1 Orbis Biosciences Inc Corporation Information
11.1.2 Orbis Biosciences Inc Description and Business Overview
11.1.3 Orbis Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Orbis Biosciences Inc Meniere Disease Drugs Products Offered
11.1.5 Orbis Biosciences Inc Related Developments
11.2 Otonomy Inc
11.2.1 Otonomy Inc Corporation Information
11.2.2 Otonomy Inc Description and Business Overview
11.2.3 Otonomy Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Otonomy Inc Meniere Disease Drugs Products Offered
11.2.5 Otonomy Inc Related Developments
11.3 Quark Pharmaceuticals Inc
11.3.1 Quark Pharmaceuticals Inc Corporation Information
11.3.2 Quark Pharmaceuticals Inc Description and Business Overview
11.3.3 Quark Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Quark Pharmaceuticals Inc Meniere Disease Drugs Products Offered
11.3.5 Quark Pharmaceuticals Inc Related Developments
11.4 Sound Pharmaceuticals Inc
11.4.1 Sound Pharmaceuticals Inc Corporation Information
11.4.2 Sound Pharmaceuticals Inc Description and Business Overview
11.4.3 Sound Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sound Pharmaceuticals Inc Meniere Disease Drugs Products Offered
11.4.5 Sound Pharmaceuticals Inc Related Developments
11.5 Synphora AB
11.5.1 Synphora AB Corporation Information
11.5.2 Synphora AB Description and Business Overview
11.5.3 Synphora AB Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Synphora AB Meniere Disease Drugs Products Offered
11.5.5 Synphora AB Related Developments
11.1 Orbis Biosciences Inc
11.1.1 Orbis Biosciences Inc Corporation Information
11.1.2 Orbis Biosciences Inc Description and Business Overview
11.1.3 Orbis Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Orbis Biosciences Inc Meniere Disease Drugs Products Offered
11.1.5 Orbis Biosciences Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Meniere Disease Drugs Market Estimates and Projections by Region
12.1.1 Global Meniere Disease Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Meniere Disease Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Meniere Disease Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Meniere Disease Drugs Sales Forecast (2021-2026)
12.2.2 North America: Meniere Disease Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Meniere Disease Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Meniere Disease Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Meniere Disease Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Meniere Disease Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Meniere Disease Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meniere Disease Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meniere Disease Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meniere Disease Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meniere Disease Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Meniere Disease Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Meniere Disease Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Meniere Disease Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Meniere Disease Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meniere Disease Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meniere Disease Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meniere Disease Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meniere Disease Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meniere Disease Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meniere Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Meniere Disease Drugs Market Segments
Table 2. Ranking of Global Top Meniere Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meniere Disease Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Vestibular Inhibitors
Table 5. Major Manufacturers of Anticholinergics
Table 6. Major Manufacturers of Vasodilator
Table 7. Major Manufacturers of Diuretic Dehydration Medicine
Table 8. Major Manufacturers of Glucocorticoids
Table 9. Major Manufacturers of Others
Table 10. Global Meniere Disease Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Meniere Disease Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Meniere Disease Drugs Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Meniere Disease Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Meniere Disease Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Meniere Disease Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Meniere Disease Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Meniere Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Meniere Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere Disease Drugs as of 2019)
Table 19. Meniere Disease Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Meniere Disease Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Meniere Disease Drugs Price (2015-2020) (USD/Pcs)
Table 22. Meniere Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Meniere Disease Drugs Product Type
Table 24. Date of International Manufacturers Enter into Meniere Disease Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 27. Global Meniere Disease Drugs Sales Share by Type (2015-2020)
Table 28. Global Meniere Disease Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Meniere Disease Drugs Revenue Share by Type (2015-2020)
Table 30. Meniere Disease Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 32. Global Meniere Disease Drugs Sales Share by Application (2015-2020)
Table 33. North America Meniere Disease Drugs Sales by Country (2015-2020) (K Pcs)
Table 34. North America Meniere Disease Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Meniere Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Meniere Disease Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 38. North America Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 40. North America Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Meniere Disease Drugs Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Meniere Disease Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Meniere Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Meniere Disease Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Meniere Disease Drugs Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Meniere Disease Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Meniere Disease Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Meniere Disease Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Meniere Disease Drugs Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Meniere Disease Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Meniere Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Meniere Disease Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Meniere Disease Drugs Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Meniere Disease Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Meniere Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Meniere Disease Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Meniere Disease Drugs Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Meniere Disease Drugs Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Table 73. Orbis Biosciences Inc Corporation Information
Table 74. Orbis Biosciences Inc Description and Major Businesses
Table 75. Orbis Biosciences Inc Meniere Disease Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Orbis Biosciences Inc Product
Table 77. Orbis Biosciences Inc Recent Development
Table 78. Otonomy Inc Corporation Information
Table 79. Otonomy Inc Description and Major Businesses
Table 80. Otonomy Inc Meniere Disease Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Otonomy Inc Product
Table 82. Otonomy Inc Recent Development
Table 83. Quark Pharmaceuticals Inc Corporation Information
Table 84. Quark Pharmaceuticals Inc Description and Major Businesses
Table 85. Quark Pharmaceuticals Inc Meniere Disease Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Quark Pharmaceuticals Inc Product
Table 87. Quark Pharmaceuticals Inc Recent Development
Table 88. Sound Pharmaceuticals Inc Corporation Information
Table 89. Sound Pharmaceuticals Inc Description and Major Businesses
Table 90. Sound Pharmaceuticals Inc Meniere Disease Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Sound Pharmaceuticals Inc Product
Table 92. Sound Pharmaceuticals Inc Recent Development
Table 93. Synphora AB Corporation Information
Table 94. Synphora AB Description and Major Businesses
Table 95. Synphora AB Meniere Disease Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Synphora AB Product
Table 97. Synphora AB Recent Development
Table 98. Global Meniere Disease Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 99. Global Meniere Disease Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 100. Global Meniere Disease Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 101. Global Meniere Disease Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 102. North America: Meniere Disease Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. North America: Meniere Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Europe: Meniere Disease Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Europe: Meniere Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Asia Pacific: Meniere Disease Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 107. Asia Pacific: Meniere Disease Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 108. Latin America: Meniere Disease Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Latin America: Meniere Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Middle East and Africa: Meniere Disease Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Middle East and Africa: Meniere Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key Meniere Disease Drugs Players
Table 116. Meniere Disease Drugs Customers List
Table 117. Meniere Disease Drugs Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Meniere Disease Drugs Product Picture
Figure 2. Global Meniere Disease Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Vestibular Inhibitors Product Picture
Figure 4. Anticholinergics Product Picture
Figure 5. Vasodilator Product Picture
Figure 6. Diuretic Dehydration Medicine Product Picture
Figure 7. Glucocorticoids Product Picture
Figure 8. Others Product Picture
Figure 9. Global Meniere Disease Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Home Care
Figure 13. Meniere Disease Drugs Report Years Considered
Figure 14. Global Meniere Disease Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Meniere Disease Drugs Sales 2015-2026 (K Pcs)
Figure 16. Global Meniere Disease Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Meniere Disease Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Meniere Disease Drugs Sales Market Share by Region in 2019
Figure 19. Global Meniere Disease Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Meniere Disease Drugs Revenue Market Share by Region in 2019
Figure 21. Global Meniere Disease Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Meniere Disease Drugs Revenue in 2019
Figure 23. Meniere Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Meniere Disease Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Meniere Disease Drugs Sales Market Share by Type in 2019
Figure 26. Global Meniere Disease Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Meniere Disease Drugs Revenue Market Share by Type in 2019
Figure 28. Global Meniere Disease Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Meniere Disease Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Meniere Disease Drugs Sales Market Share by Application in 2019
Figure 31. Global Meniere Disease Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Meniere Disease Drugs Revenue Market Share by Application in 2019
Figure 33. North America Meniere Disease Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Meniere Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Meniere Disease Drugs Sales Market Share by Country in 2019
Figure 36. North America Meniere Disease Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Meniere Disease Drugs Market Share by Type in 2019
Figure 42. North America Meniere Disease Drugs Market Share by Application in 2019
Figure 43. Europe Meniere Disease Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Meniere Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Meniere Disease Drugs Sales Market Share by Country in 2019
Figure 46. Europe Meniere Disease Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Meniere Disease Drugs Market Share by Type in 2019
Figure 58. Europe Meniere Disease Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Meniere Disease Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Meniere Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Meniere Disease Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Meniere Disease Drugs Revenue Market Share by Region in 2019
Figure 63. China Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Meniere Disease Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Meniere Disease Drugs Market Share by Application in 2019
Figure 87. Latin America Meniere Disease Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Meniere Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Meniere Disease Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Meniere Disease Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Meniere Disease Drugs Market Share by Type in 2019
Figure 98. Latin America Meniere Disease Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Meniere Disease Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Meniere Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Meniere Disease Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Meniere Disease Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Meniere Disease Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Meniere Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Meniere Disease Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Meniere Disease Drugs Market Share by Application in 2019
Figure 111. North America Meniere Disease Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Meniere Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Meniere Disease Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Meniere Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Meniere Disease Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Meniere Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Meniere Disease Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Meniere Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Meniere Disease Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Meniere Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
メニエール病の世界市場（～2026年） Ménière's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may b…- メニエール病治療の世界市場（～2026年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- クラッベ病治療薬の世界市場（～2026年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- 重症筋無力症治療薬の世界市場（～2026年） Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …
- 末梢動脈疾患（PAD）薬の世界市場（～2026年） Market Analysis and Insights: Global Peripheral Arterial Disease (PAD) Drugs Market The global Peripheral Arterial Disease (PAD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peripheral Arterial Disease (PAD) D…